EP1275381A1 — Time-release coated solid compositions for oral administration
Assigned to Astellas Pharma Inc · Expires 2003-01-15 · 23y expired
What this patent protects
The present invention relates to a timed-release compression-coated said composition for oral administration, said composition being a hydrgel-forming compression-coated solid preparation comprising a core tablet comprising a drug and an outer layer comprising a hydrogel-forming …
USPTO Abstract
The present invention relates to a timed-release compression-coated said composition for oral administration, said composition being a hydrgel-forming compression-coated solid preparation comprising a core tablet comprising a drug and an outer layer comprising a hydrogel-forming polymer substance and a hydrophilic base, characterized in that (1) said core tablet comprising a drug and a freely erodible filler, (2) said core tablet is capable of approximately 40 to approximately 90% erosion; and (3) said outer layer substantially does not comprise the same drug with said drug. By releasing a drug after a specific lag time, it becomes possible to effectively deliver a drug to a specific site in the digestive tract. It is therefore useful as presented as a timed-release solid composition for oral administration of a drug that is to be effectively delivered in high concentrations to the afflicted site in the lower digestive tract, a drug that is to be effectively absorbed in the lower digestive tract, a drug that is effective for chronopharmacotherapy, etc.
Drugs covered by this patent
- Prograf (TACROLIMUS) · Astellas Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.